CIVILICA We Respect the Science
Publisher of Iranian Journals and Conference Proceedings
Paper
title

CCND1 expression profile in different breast cancer cell lines

Credit to Download: 0 | Page Numbers 1 | Abstract Views: 63
Year: 2018
COI code: CIGS15_233
Paper Language: English

How to Download This Paper

For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.

Authors CCND1 expression profile in different breast cancer cell lines

  Fatemeh T. Shamsabadi - Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Golestan University of Medical Sciences, Gorgan, Iran.Department of Medical Biotechnology, Semnan University of Medical Sciences, Semnan, Iran
  Mohammad Reza Akbari Eidgahi - Semnan Biotechnology Research Center, Semnan University of Medical Sciences, Semnan, Iran
Ahad Yamchi - Department of biotechnology, Gorgan University of Agricultural Sciences and Natural Resources, Gorgan, Iran
  Majid Shahbazi - Medical Cellular & Molecular Research Center, Golestan University of Medical Sciences, Gorgan, Iran

Abstract:

Introduction: Cyclin D1 extensively established as an oncogene with an imperative pathogenetic role in breast cancer. Up-regulation of this gene is driven by chromosome translocation, gene amplification, polymorphism, post-transcriptional regulation and protein stability. This investigation aims at exploring the transcriptional profiling of this oncogene in various breast cancer cell lines.Methods: The transcript levels of CCND1 in 41 breast cancer cell lines obtained via GENT database which measured by Affymetrix U133A platform. CCND1 expression evaluated based on transcriptional profiling including tumor source (primary, metastasis), subtype, pathology and ER, PR and HER2 receptors.Results: Elevated level of D1 transcript observed in luminal, basal A and basal B subtypes, respectively. Compared to primary tumor, metastasis breast cancer cell lines revealed higher expression of D 1cyclin. Ductal carcinoma, carcinoma and adenocarcinoma cell lines demonstrated the higher mRNA levels in the same order. Moreover, greater expression identified in ER-, PR- and HER2+ cell lines.Conclusion: Up-regulation of CCND1 oncogene associated to the late stages of breast cancer and estrogen receptor status. The compilation of breast cancer molecular profiles defines cell lines suitable to uncover potential oncogenes, or provides a resource for better cancer prognosis.

Keywords:

CCND1, Transcriptional profiling, Breast cancer cell lines, GENT

Perma Link

https://www.civilica.com/Paper-CIGS15-CIGS15_233.html
COI code: CIGS15_233

how to cite to this paper:

If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Shamsabadi, Fatemeh T.; Mohammad Reza Akbari Eidgahi; Ahad Yamchi & Majid Shahbazi, 2018, CCND1 expression profile in different breast cancer cell lines, The Third International and 15th National Genetics Congress, تهران, انجمن علمي ژنتيك ايران, https://www.civilica.com/Paper-CIGS15-CIGS15_233.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Shamsabadi, Fatemeh T.; Mohammad Reza Akbari Eidgahi; Ahad Yamchi & Majid Shahbazi, 2018)
Second and more: (Shamsabadi; Akbari Eidgahi; Yamchi & Shahbazi, 2018)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)

Scientometrics

The University/Research Center Information:
Type: Medical University
Paper No.: 781
in University Ranking and Scientometrics the Iranian universities and research centers are evaluated based on scientific papers.

Research Info Management

Export Citation info of this paper to research management softwares

New Related Papers

Iran Scientific Advertisment Netword

Share this paper

WHAT IS COI?

COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.